Compare LCTX & FLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LCTX | FLXS |
|---|---|---|
| Founded | 1990 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 301.7M | 290.6M |
| IPO Year | 1996 | 1995 |
| Metric | LCTX | FLXS |
|---|---|---|
| Price | $1.22 | $73.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $6.25 | ★ $54.00 |
| AVG Volume (30 Days) | ★ 2.1M | 46.3K |
| Earning Date | 05-14-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 1.41% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 3.63 |
| Revenue | $14,556,000.00 | ★ $441,073,000.00 |
| Revenue This Year | $109.40 | $4.51 |
| Revenue Next Year | N/A | $4.89 |
| P/E Ratio | ★ N/A | $19.80 |
| Revenue Growth | ★ 53.24 | N/A |
| 52 Week Low | $0.93 | $32.65 |
| 52 Week High | $2.09 | $77.19 |
| Indicator | LCTX | FLXS |
|---|---|---|
| Relative Strength Index (RSI) | 42.96 | 64.67 |
| Support Level | N/A | $53.08 |
| Resistance Level | $1.35 | $77.19 |
| Average True Range (ATR) | 0.06 | 3.67 |
| MACD | -0.01 | -0.44 |
| Stochastic Oscillator | 13.89 | 49.32 |
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.
Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.